| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the computational development of androgen receptor antagonists
|
Hu, Xueping
|
|
|
25 |
8 |
p. 1453-1461
|
artikel
|
| 2 |
Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents
|
Alyassin, Yasmine
|
|
|
25 |
8 |
p. 1513-1520
|
artikel
|
| 3 |
Applications of magnetotactic bacteria and magnetosome for cancer treatment: A review emphasizing on practical and mechanistic aspects
|
Alphandéry, Edouard
|
|
|
25 |
8 |
p. 1444-1452
|
artikel
|
| 4 |
CCK2R antagonists: from SAR to clinical trials
|
Novak, Doroteja
|
|
|
25 |
8 |
p. 1322-1336
|
artikel
|
| 5 |
Contents
|
|
|
|
25 |
8 |
p. i
|
artikel
|
| 6 |
Contents
|
|
|
|
25 |
8 |
p. ii
|
artikel
|
| 7 |
COVID-19 and pneumonia: a role for the uPA/uPAR system
|
D’Alonzo, Daniele
|
|
|
25 |
8 |
p. 1528-1534
|
artikel
|
| 8 |
Current and future therapeutical approaches for COVID-19
|
Duan, Yongtao
|
|
|
25 |
8 |
p. 1545-1552
|
artikel
|
| 9 |
Discovering small-molecule therapeutics against SARS-CoV-2
|
Tiwari, Vaibhav
|
|
|
25 |
8 |
p. 1535-1544
|
artikel
|
| 10 |
Genetic profile considerations for induction of allogeneic chimerism as a therapeutic approach for type 1 diabetes mellitus
|
Black, Labe A.
|
|
|
25 |
8 |
p. 1293-1297
|
artikel
|
| 11 |
Image-based high-content screening in drug discovery
|
Lin, Sean
|
|
|
25 |
8 |
p. 1348-1361
|
artikel
|
| 12 |
Long-acting microneedles: a progress report of the state-of-the-art techniques
|
Chen, Zhongjian
|
|
|
25 |
8 |
p. 1462-1468
|
artikel
|
| 13 |
Nanovehicles for co-delivery of anticancer agents
|
Zeinali, Mahdi
|
|
|
25 |
8 |
p. 1416-1430
|
artikel
|
| 14 |
Old active ingredients in new medicinal products: is the regulatory path coherent with patients’ expectations?
|
Minghetti, Paola
|
|
|
25 |
8 |
p. 1337-1347
|
artikel
|
| 15 |
Oseltamivir analogs with potent anti-influenza virus activity
|
Kumar, Sumit
|
|
|
25 |
8 |
p. 1389-1402
|
artikel
|
| 16 |
PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity
|
Piazza, Gary A.
|
|
|
25 |
8 |
p. 1521-1527
|
artikel
|
| 17 |
pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems
|
Broesder, Annemarie
|
|
|
25 |
8 |
p. 1362-1373
|
artikel
|
| 18 |
pH-dependent ileocolonic drug delivery, part II: preclinical evaluation of novel drugs and novel excipients
|
Broesder, Annemarie
|
|
|
25 |
8 |
p. 1374-1388
|
artikel
|
| 19 |
Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells
|
Mohapatra, Priyanka
|
|
|
25 |
8 |
p. 1307-1321
|
artikel
|
| 20 |
Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
|
Villoutreix, Bruno O.
|
|
|
25 |
8 |
p. 1287-1290
|
artikel
|
| 21 |
Prophylactic aspirin for preventing pre-eclampsia and its complications: An overview of meta-analyses
|
Ghazanfarpour, Masumeh
|
|
|
25 |
8 |
p. 1487-1501
|
artikel
|
| 22 |
Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications
|
Busquets, Maria Antònia
|
|
|
25 |
8 |
p. 1431-1443
|
artikel
|
| 23 |
SCHOOL of nature: ligand-independent immunomodulatory peptides
|
Sigalov, Alexander B.
|
|
|
25 |
8 |
p. 1298-1306
|
artikel
|
| 24 |
Site-specifically deuterated essential lipids as new drugs against neuronal, retinal and vascular degeneration
|
Demidov, Vadim V.
|
|
|
25 |
8 |
p. 1469-1476
|
artikel
|
| 25 |
Targeting post-translational modification of transcription factors as cancer therapy
|
Qian, Meijia
|
|
|
25 |
8 |
p. 1502-1512
|
artikel
|
| 26 |
Tight junction modulators for drug delivery to the central nervous system
|
Hashimoto, Yosuke
|
|
|
25 |
8 |
p. 1477-1486
|
artikel
|
| 27 |
3 tips for pharma startup success
|
Cunningham, Sharon
|
|
|
25 |
8 |
p. 1291-1292
|
artikel
|
| 28 |
Treating age-related multimorbidity: the drug discovery challenge
|
Ermogenous, Christos
|
|
|
25 |
8 |
p. 1403-1415
|
artikel
|
Tijdschrift beschrijving